메뉴 건너뛰기
Clinical Infectious Diseases
Volumn 30, Issue 3, 2000, Pages 585-586
Interferon-α and ribavirin treatment of hepatitis C in children with malignancy in remission
Author keywords

[No Author keywords available]
Indexed keywords

RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;
EID: 0034035431     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313709     Document Type: Article
Times cited : (59)
References (8)
  • 1
    • 0033582180 scopus 로고    scopus 로고
    • Epidemiologic and molecular investigation of outbreaks of hepatitis C infection in a pediatric oncology service
    • 1. Widell A, Christensson B, Wiebe T, et al. Epidemiologic and molecular investigation of outbreaks of hepatitis C infection in a pediatric oncology service. Ann Intern Med 1999; 130:130-4.
    • (1999) Ann Intern Med , vol.130 , pp. 130-134
    • Widell, A.1    Christensson, B.2    Wiebe, T.3
  • 2
    • 0028126465 scopus 로고
    • Histologic activity of the liver in children with transfusion-associated chronic hepatitis C
    • 2. Inui A. Fujisawa T, Miyagawa Y, et al. Histologic activity of the liver in children with transfusion-associated chronic hepatitis C. J Hepatol 1994; 21:748-53.
    • (1994) J Hepatol , vol.21 , pp. 748-753
    • Inui, A.1    Fujisawa, T.2    Miyagawa, Y.3
  • 3
    • 0022930152 scopus 로고
    • Intron A (interferon alfa-2b): Clinical overview and future directions
    • 3. Spiegel RJ. Intron A (Interferon alfa-2b): clinical overview and future directions. Semin Oncol 1986; 13(3 Suppl2):89-101.
    • (1986) Semin Oncol , vol.13 , Issue.3 SUPPL. 2 , pp. 89-101
    • Spiegel, R.J.1
  • 4
    • 0032005872 scopus 로고    scopus 로고
    • Favorable response to lymphoblastoid interferon-alpha in children with chronic hepatitis C
    • 4. Sawada A, Tajiri H, Kozaiwa K, et al. Favorable response to lymphoblastoid interferon-alpha in children with chronic hepatitis C. J Hepatol 1998; 28: 184-8.
    • (1998) J Hepatol , vol.28 , pp. 184-188
    • Sawada, A.1    Tajiri, H.2    Kozaiwa, K.3
  • 5
    • 0031971512 scopus 로고    scopus 로고
    • Interferon treatment of children with chronic hepatitis C
    • 5. Al-Tawil Y, Nelson C. Interferon treatment of children with chronic hepatitis C. Hepatogastroenterology 1998; 45:345-8.
    • (1998) Hepatogastroenterology , vol.45 , pp. 345-348
    • Al-Tawil, Y.1    Nelson, C.2
  • 6
    • 0032585237 scopus 로고    scopus 로고
    • Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
    • 6. Poynard T, Marcellin P, Lee SS, et al. Randomised trial of Interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998; 352:1426-32.
    • (1998) Lancet , vol.352 , pp. 1426-1432
    • Poynard, T.1    Marcellin, P.2    Lee, S.S.3
  • 7
    • 0032547938 scopus 로고    scopus 로고
    • Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group
    • 7. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:1485-92.
    • (1998) N Engl J Med , vol.339 , pp. 1485-1492
    • McHutchison, J.G.1    Gordon, S.C.2    Schiff, E.R.3
  • 8
    • 0033054813 scopus 로고    scopus 로고
    • Consensus statement
    • 8. EASL International Consensus Conference on Hepatitis C. Consensus statement. J Hepatol 1999; 30:956-61.
    • (1999) J Hepatol , vol.30 , pp. 956-961

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.